Literature DB >> 22730192

Predictive value of metastatic cervical lymph node ratio in papillary thyroid carcinoma recurrence.

Jonathan Yip1, Steven Orlov, David Orlov, Alon Vaisman, Karen Gómez Hernández, Daniel Etarsky, Ipshita Kak, Nikoo Parvinnejad, Jeremy L Freeman, Paul G Walfish.   

Abstract

BACKGROUND: The purpose of this study was to determine whether the proportion of metastatic cervical lymph nodes resected (metastatic lymph node ratio [MLNR]) predicted papillary thyroid carcinoma (PTC) recurrence, and whether MLNR could alter the predictive ability of TNM nodal classification for recurrence in PTC.
METHODS: We conducted a retrospective review of patients with PTC who underwent a total or near-total thyroidectomy with at least 1 lymph node removed at our institution.
RESULTS: Of 253 patients, 35 (13.8%) developed recurrent disease. The total MLNR (ratio between total metastatic lymph nodes and total number of lymph nodes resected) independently predicted PTC recurrence (odds ratio [OR], 1.024; 95% confidence interval [CI], 1.010-1.039; p = .001). In receiver operating characteristic (ROC) curve analysis, TNM nodal classification with total MLNR had greater accuracy in predicting PTC recurrence than did TNM nodal classification alone (0.726 and 0.675, respectively).
CONCLUSION: MLNR is an independent predictor of PTC recurrence and enhances the predictive value of TNM nodal classification.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22730192     DOI: 10.1002/hed.23047

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  12 in total

1.  The clinicopathologic differences of central lymph node metastasis in predicting lateral lymph node metastasis and prognosis in papillary thyroid cancer associated with or without Hashimoto's thyroiditis.

Authors:  Youzhi Zhu; Ke Zheng; Huihao Zhang; Ling Chen; Jiajie Xue; Mingji Ding; Kunlin Wu; Zongcai Wang; Lingjun Kong; Xiangjin Chen
Journal:  Tumour Biol       Date:  2015-12-28

2.  Post-operative stimulated thyroglobulin and neck ultrasound as personalized criteria for risk stratification and radioactive iodine selection in low- and intermediate-risk papillary thyroid cancer.

Authors:  Steven Orlov; Farnaz Salari; Lawrence Kashat; Jeremy L Freeman; Allan Vescan; Ian J Witterick; Paul G Walfish
Journal:  Endocrine       Date:  2015-03-20       Impact factor: 3.633

3.  Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis?

Authors:  Hee Yong Kwak; Byung Joo Chae; Yong Hwa Eom; Young Ran Hong; Jae Beom Seo; So Hee Lee; Byung Joo Song; Sang Seol Jung; Ja Seong Bae
Journal:  Int J Clin Oncol       Date:  2014-10-15       Impact factor: 3.402

4.  Lymph node ratio as a predictor of outcome in patients with oropharyngeal cancer.

Authors:  Julian Künzel; Georgios Psychogios; Konstantinos Mantsopoulos; Philipp Grundtner; Frank Waldfahrer; Heinrich Iro
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-06-19       Impact factor: 2.503

5.  Clinical significance of Delphian lymph node metastasis in papillary thyroid carcinoma.

Authors:  Eun Mee Oh; Yoo Seung Chung; Young Don Lee
Journal:  World J Surg       Date:  2013-11       Impact factor: 3.352

6.  Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio.

Authors:  Young Woo Chang; Hwan Soo Kim; Seung Pil Jung; Hoon Yub Kim; Jae Bok Lee; Jeoung Won Bae; Gil Soo Son
Journal:  Int J Clin Oncol       Date:  2016-02-02       Impact factor: 3.402

7.  The prognostic value of regional lymph node metastases in patients of Guangdong Province, China with differentiated thyroid cancer: A multicenter retrospective clinical study.

Authors:  Lin-Yun He; Wei-Wei Wang; Balde Alpha Ibrahima; Shuai Han; Zhou Li; Zhai Cai; Miao-Liang Chen; Bao-Zhu Chen; Hui-Shi Tan; Hai-Shan Zeng; Xiao-Li Dai; Min-Wei Zhou; Gang-Qing Zhang; Guo-Xin Li
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

8.  Number of Metastatic Lymph Nodes and Ratio of Metastatic Lymph Nodes to Total Number of Retrieved Lymph Nodes Are Risk Factors for Recurrence in Patients With Clinically Node Negative Papillary Thyroid Carcinoma.

Authors:  Chuan-Ming Zheng; Yong Bae Ji; Chang Myeon Song; Ming-Hua Ge; Kyung Tae
Journal:  Clin Exp Otorhinolaryngol       Date:  2017-10-17       Impact factor: 3.372

9.  Predictive value of nodal metastases on local recurrence in the management of differentiated thyroid cancer. Retrospective clinical study.

Authors:  Giovanni Conzo; Giovanni Docimo; Daniela Pasquali; Claudio Mauriello; Claudio Gambardella; Daniela Esposito; Ernesto Tartaglia; Cristina Della Pietra; Salvatore Napolitano; Antonia Rizzuto; Luigi Santini
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

10.  Significance of micrometastases in the calculation of the lymph node ratio for papillary thyroid cancer.

Authors:  Young Woo Chang; Hwan Soo Kim; Seung Pil Jung; Hoon Yub Kim; Jae Bok Lee; Jeoung Won Bae; Gil Soo Son
Journal:  Ann Surg Treat Res       Date:  2017-02-24       Impact factor: 1.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.